Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010 (2010), Article ID 704941, 11 pages
http://dx.doi.org/10.1155/2010/704941
Research Article

Preferential Th1 Cytokine Profile of Phosphoantigen-Stimulated Human Vγ9Vδ2 T Cells

1Department of Immunology and Institute of Molecular Medicine, Trinity College Dublin, St. James's Hospital, Dublin 8, Ireland
2Institute of Immunology, National University of Ireland, Maynooth, Co. Kildare, Ireland
3National Children's Research Centre, Our Lady's Hospital for Sick Children, Crumlin, Dublin 12, Ireland

Received 10 August 2010; Revised 7 December 2010; Accepted 21 December 2010

Academic Editor: Y. Mandi

Copyright © 2010 Margaret R. Dunne et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. T. Morita, C. Jin, G. Sarikonda, and H. Wang, “Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vγ2Vδ2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens,” Immunological Reviews, vol. 215, no. 1, pp. 59–76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Moser and M. Eberl, “γδ T cells: novel initiators of adaptive immunity,” Immunological Reviews, vol. 215, no. 1, pp. 89–102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Cipriani, G. Borsellino, F. Poccia et al., “Activation of C-C β-chemokines in human peripheral blood γδ T cells by isopentenyl pyrophosphate and regulation by cytokines,” Blood, vol. 95, no. 1, pp. 39–47, 2000. View at Google Scholar · View at Scopus
  4. F. Dieli, M. Troye-Blomberg, J. Ivanyi et al., “Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by V-γ9/Vδ2 T lymphocytes,” Journal of Infectious Diseases, vol. 184, no. 8, pp. 1082–1085, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Wrobel, H. Shojaei, B. Schittek et al., “Lysis of a broad range of epithelial tumour cells by human γδ T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition,” Scandinavian Journal of Immunology, vol. 66, no. 2-3, pp. 320–328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Lehner, E. Mitchell, L. Bergmeier et al., “The role of ?d T cells in generating antiviral factors and ß-chemokines in protection against mucosal simian immunodeficiency virus infection,” European Journal of Immunology, vol. 30, no. 8, pp. 2245–2256, 2000. View at Google Scholar
  7. S. Dudal, C. Turriere, S. Bessoles et al., “Release of LL-37 by activated human Vγ9Vδ2 T cells: a microbicidal weapon against Brucella suis,” Journal of Immunology, vol. 177, no. 8, pp. 5533–5539, 2006. View at Google Scholar · View at Scopus
  8. G. Workalemahu, M. Foerster, and C. Kroegel, “Expression and synthesis of fibroblast growth factor-9 in human γδ T-lymphocytes. Response to isopentenyl pyrophosphate and TGF-β1/IL-15,” Journal of Leukocyte Biology, vol. 75, no. 4, pp. 657–663, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Workalemahu, M. Foerster, C. Kroegel, and R. K. Braun, “Human γδ-T lymphocytes express and synthesize connective tissue growth factor: effect of IL-15 and TGF-β1 and comparison with αβ-T lymphocytes,” Journal of Immunology, vol. 170, no. 1, pp. 153–157, 2003. View at Google Scholar · View at Scopus
  10. C. Agrati, E. Cimini, A. Sacchi et al., “Activated Vγ9Vδ2 T cells trigger granulocyte functions via MCP-2 release,” Journal of Immunology, vol. 182, no. 1, pp. 522–529, 2009. View at Google Scholar · View at Scopus
  11. N. Caccamo, L. Battistini, M. Bonneville et al., “CXCR5 identifies a subset of Vγ9Vδ2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production,” Journal of Immunology, vol. 177, no. 8, pp. 5290–5295, 2006. View at Google Scholar · View at Scopus
  12. M. Eberl, G. W. Roberts, S. Meuter, J. D. Williams, N. Topley, and B. Moser, “A rapid crosstalk of human γδ T cells and monocytes drives the acute inflammation in bacterial infections,” PLoS Pathogens, vol. 5, no. 2, Article ID e1000308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Ismaili, V. Olislagers, R. Poupot, J. J. Fournié, and M. Goldman, “Human γδ T cells induce dendritic cell maturation,” Clinical Immunology, vol. 103, no. 3, pp. 296–302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Conti, R. Casetti, M. Cardone et al., “Reciprocal activating interaction between dendritic cells and pamidronate-stimulated γδ T cells: role of CD86 and inflammatory cytokines,” Journal of Immunology, vol. 174, no. 1, pp. 252–260, 2005. View at Google Scholar · View at Scopus
  15. M. C. Devilder, S. Maillet, I. Bouyge-Moreau, E. Bonnadieu, M. Bonneville, and E. Scotet, “Potentiation of antigen-stimulated Vγ9Vδ2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation,” Journal of Immunology, vol. 176, no. 3, pp. 1386–1393, 2006. View at Google Scholar · View at Scopus
  16. M. R. Dunne, L. Madrigal-Estebas, L. M. Tobin, and D. G. Doherty, “(E)-4-hydroxy-3-methyl-but-2 enyl pyrophosphate-stimulated Vγ9Vδ2 T cells possess T helper type 1-promoting adjuvant activity for human monocyte-derived dendritic cells,” Cancer Immunology, Immunotherapy, vol. 59, no. 7, pp. 1109–1120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Brandes, K. Willimann, and B. Moser, “Immunology: professional antigen-presentation function by human γδ cells,” Science, vol. 309, no. 5732, pp. 264–268, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Meuter, M. Eberl, and B. Moser, “Prolonged antigen survival and cytosolic export in cross-presenting human γδ T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 19, pp. 8730–8735, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Fisch, M. Malkovsky, S. Kovats et al., “Recognition by human Vγ9Vδ2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells,” Science, vol. 250, no. 4985, pp. 1269–1273, 1990. View at Google Scholar · View at Scopus
  20. E. Viey, G. Fromont, B. Escudier et al., “Phosphostim-activated γδ T cells kill autologous metastatic renal cell carcinoma,” Journal of Immunology, vol. 174, no. 3, pp. 1338–1347, 2005. View at Google Scholar · View at Scopus
  21. S. R. Mattarollo, T. Kenna, M. Nieda, and A. J. Nicol, “Chemotherapy and zoledronate sensitize solid tumour cells to Vγ9Vδ2 T cell cytotoxicity,” Cancer Immunology, Immunotherapy, vol. 56, no. 8, pp. 1285–1297, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Wilhelm, V. Kunzmann, S. Eckstein et al., “γδ T cells for immune therapy of patients with lymphoid malignancies,” Blood, vol. 102, no. 1, pp. 200–206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Bennouna, E. Bompas, E. M. Neidhardt et al., “Phase-I study of Innacell γδ, an autologous cell-therapy product highly enriched in Vγ9Vδ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma,” Cancer Immunology, Immunotherapy, vol. 57, no. 11, pp. 1599–1609, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Kobayashi, Y. Tanaka, H. Shimmura, N. Minato, and K. Tanabe, “Complete remission of lung metastasis following adoptive immunotherapy using activated autologous γδ T-cells in a patient with renal cell carcinoma,” Anticancer Research, vol. 30, no. 2, pp. 575–579, 2010. View at Google Scholar · View at Scopus
  25. J. Nakajima, T. Murakawa, T. Fukami et al., “A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells,” European Journal of Cardio-Thoracic Surgery, vol. 37, no. 5, pp. 1191–1197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Dieli, D. Vermijlen, F. Fulfaro et al., “Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer,” Cancer Research, vol. 67, no. 15, pp. 7450–7457, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. H. J. Gober, M. Kistowska, L. Angman, P. Jenö, L. Mori, and G. De Libero, “Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells,” Journal of Experimental Medicine, vol. 197, no. 2, pp. 163–168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. D. A. Ferrick, M. D. Schrenzel, T. Mulvania, B. Hsieh, W. C. Ferlin, and H. Lepper, “Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo,” Nature, vol. 373, no. 6511, pp. 255–257, 1995. View at Google Scholar · View at Scopus
  29. L. Wen, D. F. Barber, W. Pao, F. S. Wong, M. J. Owen, and A. Hayday, “Primary γδ cell clones can be defined phenotypically and functionally as Th1/Th2 cells and illustrate the association of CD4 with Th2 differentiation,” Journal of Immunology, vol. 160, no. 4, pp. 1965–1974, 1998. View at Google Scholar · View at Scopus
  30. A. Hayday and R. Tigelaar, “Immunoregulation in the tissues by γδ T cells,” Nature Reviews Immunology, vol. 3, no. 3, pp. 233–242, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Martin, K. Hirota, D. J. Cua, B. Stockinger, and M. Veldhoen, “Interleukin-17-producing γδ T cells selectively expand in response to pathogen products and environmental signals,” Immunity, vol. 31, no. 2, pp. 321–330, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. C. E. Sutton, S. J. Lalor, C. M. Sweeney, C. F. Brereton, ED. C. Lavelle, and K. H. G. Mills, “Interleukin-1 and IL-23 induce innate IL-17 production from γδ T cells, amplifying Th17 responses and autoimmunity,” Immunity, vol. 31, no. 2, pp. 331–341, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. V. E. García, P. A. Sieling, J. Gong et al., “Single-cell cytokine analysis of γδ T cell responses to nonpeptide mycobacterial antigens,” Journal of Immunology, vol. 159, no. 3, pp. 1328–1335, 1997. View at Google Scholar · View at Scopus
  34. K. Tsukaguchi, B. De Lange, and W. H. Boom, “Differential regulation of IFN-γ, TNF-α, and IL-10 production by CD4+αβTCR+ T cells and Vδ2 γδ T cells in response to monocytes infected with Mycobacterium tuberculosis-H37Ra,” Cellular Immunology, vol. 194, no. 1, pp. 12–20, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Wesch, A. Glatzel, and D. Kabelitz, “Differentiation of resting human peripheral blood γδ T cells toward Th1- or Th2-phenotype,” Cellular Immunology, vol. 212, no. 2, pp. 110–117, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Eberl, R. Engel, E. Beck, and H. Jomaa, “Differentiation of human γδ T cells towards distinct memory phenotypes,” Cellular Immunology, vol. 218, no. 1-2, pp. 1–6, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. D. F. Angelini, G. Borsellino, M. Poupot et al., “FcγRIII discriminates between 2 subsets of Vγ9Vδ2 effector cells with different responses and activation pathways,” Blood, vol. 104, no. 6, pp. 1801–1807, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Vermijlen, P. Ellis, C. Langford et al., “Distinct cytokine-driven responses of activated blood γδ T cells: insights into unconventional T cell pleiotropy,” Journal of Immunology, vol. 178, no. 7, pp. 4304–4314, 2007. View at Google Scholar · View at Scopus
  39. K. J. Ness-Schwickerath, C. Jin, and C. T. Morita, “Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vγ9Vδ2 T cells,” Journal of Immunology, vol. 184, no. 12, pp. 7268–7280, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Hintz, A. Reichenberg, B. Altincicek et al., “Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human γδ T cells in Escherichia coli,” FEBS Letters, vol. 509, no. 2, pp. 317–322, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Eberl, M. Hintz, A. Reichenberg, A. K. Kollas, J. Wiesner, and H. Jomaa, “Microbial isoprenoid biosynthesis and human γδ T cell activation,” FEBS Letters, vol. 544, no. 1–3, pp. 4–10, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Reichenberg, M. Hintz, Y. Kletschek et al., “Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates its potential to activate human γδ T cells but does not lead to competitive antagonism,” Bioorganic and Medicinal Chemistry Letters, vol. 13, no. 7, pp. 1257–1260, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. D. G. Doherty, S. Norris, L. Madrigal-Estebas et al., “The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns,” Journal of Immunology, vol. 163, no. 4, pp. 2314–2321, 1999. View at Google Scholar · View at Scopus
  44. D. V. Correia, F. D'Orey, B. A. Cardoso et al., “Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human γδ T-cells,” PLoS One, vol. 4, no. 5, Article ID e5657, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Pietschmann, S. Beetz, S. Welte et al., “Toll-like receptor expression and function in subsets of human γδ T lymphocytes,” Scandinavian Journal of Immunology, vol. 70, no. 3, pp. 245–255, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Shojaei, H. H. Oberg, M. Juricke et al., “Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human γδ T cells,” Cancer Research, vol. 69, no. 22, pp. 8710–8717, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Bauer, V. Groh, J. Wu et al., “Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA,” Science, vol. 285, no. 5428, pp. 727–729, 1999. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Tanaka, C. T. Morita, Y. Tanaka, E. Nieves, M. B. Brenner, and B. R. Bloom, “Natural and synthetic non-peptide antigens recognized by human γδ T cells,” Nature, vol. 375, no. 6527, pp. 155–158, 1995. View at Google Scholar · View at Scopus
  49. A. Bendelac, P. B. Savage, and L. Teyton, “The biology of NKT cells,” Annual Review of Immunology, vol. 25, pp. 297–336, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. C. T. Morita, E. M. Beckman, J. F. Bukowski et al., “Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells,” Immunity, vol. 3, no. 4, pp. 495–507, 1995. View at Publisher · View at Google Scholar · View at Scopus
  51. X. Lafarge, V. Pitard, S. Ravet et al., “Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of γδ T cells,” European Journal of Immunology, vol. 35, no. 6, pp. 1896–1905, 2005. View at Publisher · View at Google Scholar · View at Scopus